NASDAQ:AWH Aspira Women's Health (AWH) Stock Price, News & Analysis → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free AWH Stock Alerts $3.65 +0.05 (+1.39%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$3.54▼$3.8150-Day Range$3.60▼$5.6352-Week Range$2.31▼$7.76Volume14,649 shsAverage Volume32,450 shsMarket Capitalization$37.74 millionP/E RatioN/ADividend YieldN/APrice Target$4.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Aspira Women's Health alerts: Email Address Aspira Women's Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside31.5% Upside$4.80 Price TargetShort InterestBearish3.24% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.03) to ($0.93) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.11 out of 5 starsMedical Sector795th out of 947 stocksDiagnostic Substances Industry12th out of 13 stocks 3.3 Analyst's Opinion Consensus RatingAspira Women's Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.80, Aspira Women's Health has a forecasted upside of 31.5% from its current price of $3.65.Amount of Analyst CoverageAspira Women's Health has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.24% of the float of Aspira Women's Health has been sold short.Short Interest Ratio / Days to CoverAspira Women's Health has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Aspira Women's Health has recently increased by 1.80%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAspira Women's Health does not currently pay a dividend.Dividend GrowthAspira Women's Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AWH. Previous Next 2.1 News and Social Media Coverage News SentimentAspira Women's Health has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Aspira Women's Health this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for AWH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aspira Women's Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aspira Women's Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.90% of the stock of Aspira Women's Health is held by insiders.Percentage Held by InstitutionsOnly 31.85% of the stock of Aspira Women's Health is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aspira Women's Health are expected to grow in the coming year, from ($2.03) to ($0.93) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aspira Women's Health is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aspira Women's Health is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAspira Women's Health has a P/B Ratio of 4.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Bull ReportThe AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.Click here to see who's preparing to meet these needs About Aspira Women's Health Stock (NASDAQ:AWH)Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering. Its product pipeline includes OvaWatch, a non-invasive blood-based risk assessment test to determine ovarian cancer risk for patients with an adnexal mass; and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. In addition, the company operates Aspira Synergy, a testing platform and cloud service; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.Read More AWH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AWH Stock News HeadlinesMarch 18, 2024 | finance.yahoo.comAspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as PresidentMarch 11, 2024 | finance.yahoo.comAspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024March 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.March 11, 2024 | globenewswire.comAspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024February 22, 2024 | finance.yahoo.comAspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer ConferenceFebruary 22, 2024 | globenewswire.comAspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer ConferenceFebruary 21, 2024 | benzinga.comFirst Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health StocksFebruary 12, 2024 | finance.yahoo.comAspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)March 19, 2024 | Porter & Company (Ad)Urgent new message from Porter StansberryI’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024.February 6, 2024 | finance.yahoo.comAspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the PhilippinesJanuary 25, 2024 | markets.businessinsider.comAspira Women's Health Announces $5.5 Mln Direct Offering, Private Placement; Stock Up In Pre-marketJanuary 25, 2024 | finance.yahoo.comOptimizeRx Announces Strategic Board Changes to Support Growth and Evolving LandscapeJanuary 25, 2024 | finance.yahoo.comAspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private PlacementJanuary 9, 2024 | morningstar.comAspira Womens Health IncJanuary 4, 2024 | finance.yahoo.comBullish Aspira Women's Health Insiders Loaded Up On US$702.9k Of StockDecember 19, 2023 | finance.yahoo.comAspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024December 14, 2023 | finance.yahoo.comAspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024December 8, 2023 | finance.yahoo.comNew to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PTDecember 7, 2023 | msn.comAspira Women's Health CEO Nicole Sandford discloses purchase of over 5K sharesDecember 6, 2023 | finance.yahoo.comAspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for EndometriosisNovember 28, 2023 | finanznachrichten.deAspira Women's Health Inc.: Aspira Women's Health Reports Third Quarter 2023 Financial ResultsNovember 28, 2023 | finance.yahoo.comAspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)November 27, 2023 | benzinga.comAspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)November 27, 2023 | finance.yahoo.comAspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)November 14, 2023 | finance.yahoo.comAspira Women’s Health Inc. (NASDAQ:AWH) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | benzinga.comAspira Womens Health: Q3 Earnings InsightsNovember 13, 2023 | finance.yahoo.comAspira Women’s Health Reports Third Quarter 2023 Financial ResultsSee More Headlines Receive AWH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspira Women's Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today3/18/2024Next Earnings (Confirmed)3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:AWH CUSIPN/A CIK926617 Webwww.aspirawh.com Phone512-519-0400Fax512-439-6908Employees85Year FoundedN/APrice Target and Rating Average Stock Price Target$4.80 High Stock Price Target$5.60 Low Stock Price Target$4.00 Potential Upside/Downside+31.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($12.3047) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,890,000.00 Net Margins-198.22% Pretax Margin-192.67% Return on Equity-1,099.32% Return on Assets-160.80% Debt Debt-to-Equity RatioN/A Current Ratio1.47 Quick Ratio1.41 Sales & Book Value Annual Sales$8.18 million Price / Sales4.61 Cash FlowN/A Price / Cash FlowN/A Book Value$0.84 per share Price / Book4.35Miscellaneous Outstanding Shares10,340,000Free Float9,830,000Market Cap$37.74 million OptionableNo Data Beta1.66 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMs. Nicole Sandford CPA (Age 54)President, CEO & Director Comp: $500.49kMs. Minh Merchant (Age 51)General Counsel & Corporate Secretary Comp: $325.92kDr. Torsten Hombeck Ph.D. (Age 54)Senior VP & CFO Dr. Jody Berry Ph.D.Chief Scientific OfficerMs. Michelle SniderSenior Vice President of Commercial Strategy & OperationsKey CompetitorsImmuCellNASDAQ:ICCCCardio DiagnosticsNASDAQ:CDIOOncoCyteNASDAQ:OCXARCA biopharmaNASDAQ:ABIOTrinity BiotechNASDAQ:TRIBView All CompetitorsInsiders & InstitutionsB. Riley Wealth Advisors Inc.Bought 53,997 shares on 3/15/2024Ownership: 1.735%Vanguard Group Inc.Bought 13,162 shares on 3/11/2024Ownership: 1.896%Vanguard Group Inc.Bought 13,162 shares on 2/15/2024Ownership: 1.896%Northern Trust CorpBought 25,047 shares on 2/13/2024Ownership: 0.349%Quantum Private Wealth LLCBought 21,788 shares on 1/30/2024Ownership: 0.485%View All Insider TransactionsView All Institutional Transactions AWH Stock Analysis - Frequently Asked Questions Should I buy or sell Aspira Women's Health stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AWH shares. View AWH analyst ratings or view top-rated stocks. What is Aspira Women's Health's stock price target for 2024? 2 Wall Street analysts have issued twelve-month price objectives for Aspira Women's Health's shares. Their AWH share price targets range from $4.00 to $5.60. On average, they predict the company's stock price to reach $4.80 in the next twelve months. This suggests a possible upside of 31.5% from the stock's current price. View analysts price targets for AWH or view top-rated stocks among Wall Street analysts. How have AWH shares performed in 2024? Aspira Women's Health's stock was trading at $4.08 at the beginning of 2024. Since then, AWH stock has decreased by 10.5% and is now trading at $3.65. View the best growth stocks for 2024 here. When is Aspira Women's Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024. View our AWH earnings forecast. How can I listen to Aspira Women's Health's earnings call? Aspira Women's Health will be holding an earnings conference call on Thursday, March 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Aspira Women's Health's earnings last quarter? Aspira Women's Health Inc. (NASDAQ:AWH) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($1.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.05) by $0.30. The firm had revenue of $1.67 million for the quarter, compared to analysts' expectations of $1.50 million. Aspira Women's Health had a negative net margin of 198.22% and a negative trailing twelve-month return on equity of 1,099.32%. During the same period in the previous year, the firm posted ($0.60) earnings per share. When did Aspira Women's Health's stock split? Shares of Aspira Women's Health reverse split on the morning of Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What is Scott A. Carmilani's approval rating as Aspira Women's Health's CEO? 33 employees have rated Aspira Women's Health Chief Executive Officer Scott A. Carmilani on Glassdoor.com. Scott A. Carmilani has an approval rating of 92% among the company's employees. This puts Scott A. Carmilani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 97.0% of employees surveyed would recommend working at Aspira Women's Health to a friend. What other stocks do shareholders of Aspira Women's Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and Who are Aspira Women's Health's major shareholders? Aspira Women's Health's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.90%), Vanguard Group Inc. (1.90%), B. Riley Wealth Advisors Inc. (1.73%), Quantum Private Wealth LLC (0.49%), Northern Trust Corp (0.35%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jack W Schuler, Minh Hoang Merchant, Nicole Sandford, Ryan Thinh Phan, Torsten Hombeck, Valerie Barber Palmieri and Veronica Gh Jordan. View institutional ownership trends. How do I buy shares of Aspira Women's Health? Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AWH) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspira Women's Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.